|
Palo Alto, CA, September 11, 2003 — Telik, Inc. (Nasdaq:
TELK) announced the election of May Ann Gray, Ph.D., to the company’s
Board of Directors.
Dr. Gray has extensive experience in the biotechnology and pharmaceutical
industries, most recently as Senior Analyst and Portfolio Manager
for the Federated Kaufmann Fund. Previously, Dr. Gray led biotechnology
equity research groups at Raymond James & Associates, Warburg
Dillon Read and Kidder Peabody. Dr. Gray began her career as a scientist
focused on new cancer drug development at Schering-Plough and NeoRx
Corporation. She is currently president of Gray Strategic Advisors,
LLC, a biotechnology strategic planning and advisory firm. Dr. Gray
holds a Ph.D. in pharmacology from the University of Vermont.
“We are very pleased that Dr. Gray has joined our Board
of Directors, and that we will have the benefit of her knowledge
and experience in the biopharmaceutical industry, as well as in
cancer drug discovery and development,” said Michael M. Wick,
M.D., Ph.D., chairman and chief executive officer. “In addition,
we look forward to working with her on the prioritization of our
rich product pipeline.”
Telik, Inc. of Palo Alto, CA is a biopharmaceutical company working
to discover, develop and commercialize small molecule drugs to treat
serious diseases for which there is significant demand for new therapies.
The company’s most advanced drug development candidate is
TELCYTA™ (TLK286), in a Phase 3 registration trial in advanced
ovarian cancer and in Phase 2 clinical trials in ovarian, non-small
cell lung and breast cancer. TLK199 is in a Phase 1-2a trial in
myelodysplastic syndrome, a form of pre-leukemia. Telik’s
product candidates were discovered using its proprietary drug discovery
technology, TRAP, which enables the rapid and efficient discovery
of small molecule drug candidates. Additional information is available
at www.telik.com.
###
Contact:
Carol DeGuzman
Senior Director, Corporate Communications
Telik, Inc.
Tel 650-845-7728
Email cdeguzman@telik.com
Go to: 2003
Press Releases2004
Press ReleasesEvents
|
